Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
1.
Respir Res ; 22(1): 300, 2021 Nov 22.
Artículo en Inglés | MEDLINE | ID: mdl-34809630

RESUMEN

BACKGROUND: Previous studies have determined the epigenetic association between DNA methylation and pulmonary function among various ethnics, whereas this association is largely unknown in Chinese adults. Thus, we aimed to explore epigenetic relationships between genome-wide DNA methylation levels and pulmonary function among middle-aged Chinese monozygotic twins. METHODS: The monozygotic twin sample was drawn from the Qingdao Twin Registry. Pulmonary function was measured by three parameters including forced expiratory volume the first second (FEV1), forced vital capacity (FVC), and FEV1/FVC ratio. Linear mixed effect model was used to regress the methylation level of CpG sites on pulmonary function. After that, we applied Genomic Regions Enrichment of Annotations Tool (GREAT) to predict the genomic regions enrichment, and used comb-p python library to detect differentially methylated regions (DMRs). Gene expression analysis was conducted to validate the results of differentially methylated analyses. RESULTS: We identified 112 CpG sites with the level of P < 1 × 10-4 which were annotated to 40 genes. We identified 12 common enriched pathways of three pulmonary function parameters. We detected 39 DMRs located at 23 genes, of which PRDM1 was related to decreased pulmonary function, and MPL, LTB4R2, and EPHB3 were related to increased pulmonary function. The gene expression analyses validated DIP2C, ASB2, SLC6A5, and GAS6 related to decreased pulmonary function. CONCLUSION: Our DNA methylation sequencing analysis on identical twins provides new references for the epigenetic regulation on pulmonary function. Several CpG sites, genes, biological pathways and DMRs are considered as possible crucial to pulmonary function.


Asunto(s)
Enfermedades Cardiovasculares/genética , Enfermedades en Gemelos/genética , Volumen Espiratorio Forzado/fisiología , Regulación de la Expresión Génica , Estudio de Asociación del Genoma Completo/métodos , Factor 1 de Unión al Dominio 1 de Regulación Positiva/genética , Gemelos Monocigóticos/genética , Anciano , Enfermedades Cardiovasculares/epidemiología , Enfermedades Cardiovasculares/metabolismo , China/epidemiología , Metilación de ADN , Enfermedades en Gemelos/epidemiología , Femenino , Humanos , Incidencia , Pulmón/fisiopatología , Masculino , Persona de Mediana Edad , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Regiones Promotoras Genéticas , Sistema de Registros , Capacidad Vital/fisiología , Dedos de Zinc
2.
J Cell Physiol ; 236(7): 5098-5107, 2021 07.
Artículo en Inglés | MEDLINE | ID: mdl-33305824

RESUMEN

Immunoreceptors expressed on osteoclast precursor cells modify osteoclast differentiation and bone resorption activity. Dectin-1 is a lectin receptor of ß-glucan and is specifically expressed in osteoclast precursor cells. In this study, we evaluated the bioactivity of ß-glucan on receptor activator of nuclear factor-kappa B ligand (RANKL)-induced osteoclastogenesis and observed that glucan from baker's yeast inhibited this process in mouse bone marrow cells and dectin-1-overexpressing RAW264.7 (d-RAW) cells. In conjunction, RANKL-induced nuclear factor of activated T cell c1 expression was suppressed, subsequently downregulating TRAP and Oc-stamp. Additionally, nuclear factor-kappa B activation and the expression of c-fos and Blimp1 were reduced in d-RAW cells. Furthermore, glucan from baker's yeast induced the degradation of Syk protein, essential factor for osteoclastogenesis. These results suggest that glucan from baker's yeast suppresses RANKL-induced osteoclastogenesis and can be applied as a new treatment strategy for bone-related diseases.


Asunto(s)
Lectinas Tipo C/metabolismo , Osteoclastos/citología , Osteogénesis/fisiología , Ligando RANK/metabolismo , Saccharomyces cerevisiae/metabolismo , beta-Glucanos/metabolismo , Animales , Resorción Ósea/patología , Línea Celular , Proteínas de la Membrana/metabolismo , Ratones , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Proteínas Proto-Oncogénicas c-fos/biosíntesis , Células RAW 264.7 , Fosfatasa Ácida Tartratorresistente/metabolismo
3.
Dev Biol ; 464(2): 111-123, 2020 08 15.
Artículo en Inglés | MEDLINE | ID: mdl-32562755

RESUMEN

The transcription factors Prdm1 (Blimp1) and Vsx2 (Chx10) work downstream of Otx2 to regulate photoreceptor and bipolar cell fates in the developing retina. Mice that lack Vsx2 fail to form bipolar cells while Prdm1 mutants form excess bipolars at the direct expense of photoreceptors. Excess bipolars in Prdm1 mutants appear to derive from rods, suggesting that photoreceptor fate remains mutable for some time after cells become specified. Here we tested whether bipolar cell fate is also plastic during development. To do this, we created a system to conditionally misexpress Prdm1 at different stages of bipolar cell development. We found that Prdm1 blocks bipolar cell formation if expressed before the fate choice decision occurred. When we misexpressed Prdm1 just after the decision to become a bipolar cell was made, some cells were reprogrammed into photoreceptors. In contrast, Prdm1 misexpression in mature bipolar cells did not affect cell fate. We also provide evidence that sustained misexpression of Prdm1 was selectively toxic to photoreceptors. Our data show that bipolar fate is malleable, but only for a short temporal window following fate specification. Prdm1 and Vsx2 act by stabilizing photoreceptor and bipolar fates in developing OTX2+ cells of the retina.


Asunto(s)
Reprogramación Celular , Regulación del Desarrollo de la Expresión Génica , Células Fotorreceptoras de Vertebrados/metabolismo , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Animales , Proteínas de Homeodominio/genética , Proteínas de Homeodominio/metabolismo , Ratones , Ratones Transgénicos , Mutación , Factores de Transcripción Otx/genética , Factores de Transcripción Otx/metabolismo , Células Fotorreceptoras de Vertebrados/citología , Factor 1 de Unión al Dominio 1 de Regulación Positiva/genética , Factores de Transcripción/genética , Factores de Transcripción/metabolismo
4.
Immunity ; 50(5): 1172-1187.e7, 2019 05 21.
Artículo en Inglés | MEDLINE | ID: mdl-31076359

RESUMEN

Although viral infections elicit robust interferon-γ (IFN-γ) and long-lived antibody-secreting cell (ASC) responses, the roles for IFN-γ and IFN-γ-induced transcription factors (TFs) in ASC development are unclear. We showed that B cell intrinsic expression of IFN-γR and the IFN-γ-induced TF T-bet were required for T-helper 1 cell-induced differentiation of B cells into ASCs. IFN-γR signaling induced Blimp1 expression in B cells but also initiated an inflammatory gene program that, if not restrained, prevented ASC formation. T-bet did not affect Blimp1 upregulation in IFN-γ-activated B cells but instead regulated chromatin accessibility within the Ifng and Ifngr2 loci and repressed the IFN-γ-induced inflammatory gene program. Consistent with this, B cell intrinsic T-bet was required for formation of long-lived ASCs and secondary ASCs following viral, but not nematode, infection. Therefore, T-bet facilitates differentiation of IFN-γ-activated inflammatory effector B cells into ASCs in the setting of IFN-γ-, but not IL-4-, induced inflammatory responses.


Asunto(s)
Linfocitos B/inmunología , Interferón gamma/inmunología , Receptores de Interferón/metabolismo , Proteínas de Dominio T Box/metabolismo , Linfocitos T Colaboradores-Inductores/inmunología , Animales , Células Productoras de Anticuerpos/inmunología , Linfocitos B/citología , Diferenciación Celular/inmunología , Células Cultivadas , Cromatina/metabolismo , Subtipo H1N1 del Virus de la Influenza A/inmunología , Subtipo H3N2 del Virus de la Influenza A/inmunología , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Nematospiroides dubius/inmunología , Infecciones por Orthomyxoviridae/inmunología , Infecciones por Orthomyxoviridae/virología , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Infecciones por Strongylida/inmunología , Infecciones por Strongylida/parasitología , Proteínas de Dominio T Box/genética , Receptor de Interferón gamma
5.
Cell Prolif ; 52(1): e12530, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30334302

RESUMEN

OBJECTIVES: In vitro differentiation of oocytes from female germline stem cells (FGSCs) has exciting potential applications for reproductive medicine. Some researchers have attempted to reveal the in vitro differentiation capacity of FGSCs. However, no systematic comparative study of in vitro differentiation conditions has been performed for murine FGSCs (mFGSCs). MATERIALS AND METHODS: mFGSCs line was cultured under five different conditions for in vitro differentiation. RT-PCR was performed to detect the expression of Oct4, Fragilis, Blimp1, Mvh, Scp3 and Zp3. Immunofluorescence was carried out to test the expression of Mvh, Fragilis and Zp3. Two-photon laser-scanning microscope was used to analyze nucleus-plasma ratio, and the proportion of chromatin of GV oocytes differentiated from mFGSCs in vitro (IVD-GVO), GV oocytes from in vivo (GVO) and mFGSCs. RESULTS: RT-PCR and immunofluorescence showed that mFGSC line expressed germ cell-specific markers, but not a meiosis-specific marker. By evaluating five different in vitro differentiation conditions, condition 5, which included a hanging drop procedure and co-culture of mFGSCs with granulosa cells, was shown to be optimal. mFGSCs could be successfully differentiated into germinal vesicle (GV) -stage oocytes under this condition. 3D observation revealed that both the nucleus-plasma ratio and proportion of chromatin were not significantly different between IVD-GVO and GVO. CONCLUSION: We evaluated five in vitro differentiation conditions for mFGSCs and successfully differentiate mFGSCs into GV-stage oocytes using a three-step differentiation process.


Asunto(s)
Células de la Granulosa/citología , Oocitos/citología , Oogénesis/fisiología , Animales , Técnicas de Cultivo de Célula , Proteínas de Ciclo Celular , Células Cultivadas , ARN Helicasas DEAD-box/biosíntesis , Proteínas de Unión al ADN , Femenino , Proteínas de la Membrana/biosíntesis , Ratones , Proteínas Nucleares/biosíntesis , Factor 3 de Transcripción de Unión a Octámeros/biosíntesis , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Glicoproteínas de la Zona Pelúcida/biosíntesis
6.
Immunity ; 48(4): 659-674.e6, 2018 04 17.
Artículo en Inglés | MEDLINE | ID: mdl-29669249

RESUMEN

T cell receptor (TCR) stimulation of naive CD8+ T cells initiates reprogramming of cis-regulatory landscapes that specify effector and memory cytotoxic T lymphocyte (CTL) differentiation. We mapped regions of hyper-accessible chromatin in naive cells during TCR stimulation and discovered that the transcription factor (TF) Runx3 promoted accessibility to memory CTL-specific cis-regulatory regions before the first cell division and was essential for memory CTL differentiation. Runx3 was specifically required for accessibility to regions highly enriched with IRF, bZIP and Prdm1-like TF motifs, upregulation of TFs Irf4 and Blimp1, and activation of fundamental CTL attributes in early effector and memory precursor cells. Runx3 ensured that nascent CTLs differentiated into memory CTLs by preventing high expression of the TF T-bet, slowing effector cell proliferation, and repressing terminal CTL differentiation. Runx3 overexpression enhanced memory CTL differentiation during iterative infections. Thus, Runx3 governs chromatin accessibility during TCR stimulation and enforces the memory CTL developmental program.


Asunto(s)
Cromatina/metabolismo , Subunidad alfa 3 del Factor de Unión al Sitio Principal/metabolismo , Memoria Inmunológica/inmunología , Receptores de Antígenos de Linfocitos T/inmunología , Linfocitos T Citotóxicos/citología , Linfocitos T Citotóxicos/inmunología , Animales , Sitios de Unión/inmunología , Diferenciación Celular/inmunología , Línea Celular , Proliferación Celular , Chlorocebus aethiops , Cricetinae , Activación Enzimática/inmunología , Femenino , Humanos , Factores Reguladores del Interferón/biosíntesis , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Noqueados , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Células Vero
7.
Nat Commun ; 8(1): 1443, 2017 11 13.
Artículo en Inglés | MEDLINE | ID: mdl-29129929

RESUMEN

Plasma cell differentiation is a tightly regulated process that requires appropriate T cell helps to reach the induction threshold. To further understand mechanisms by which T cell inputs regulate B cell fate decision, we investigate the minimal IL-2 stimulation for triggering human plasma cell differentiation in vitro. Here we show that the timed repression of BACH2 through IL-2-mediated ERK/ELK1 signalling pathway directs plasma cell lineage commitment. Enforced BACH2 repression in activated B cells unlocks the plasma cell transcriptional program and induces their differentiation into immunoglobulin M-secreting cells. RNA-seq and ChIP-seq results further identify BACH2 target genes involved in this process. An active regulatory region within the BACH2 super-enhancer, under ELK1 control and differentially regulated upon B-cell activation and cellular divisions, helps integrate IL-2 signal. Our study thus provides insights into the temporal regulation of BACH2 and its targets for controlling the differentiation of human naive B cells.


Asunto(s)
Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/antagonistas & inhibidores , Diferenciación Celular/inmunología , Quinasas MAP Reguladas por Señal Extracelular/metabolismo , Interleucina-2/inmunología , Células Plasmáticas/citología , Proteína Elk-1 con Dominio ets/metabolismo , Factores de Transcripción con Cremalleras de Leucina de Carácter Básico/genética , Células Cultivadas , Redes Reguladoras de Genes/inmunología , Humanos , Inmunoglobulina M/biosíntesis , Inmunoglobulina M/inmunología , Activación de Linfocitos/inmunología , Células Plasmáticas/inmunología , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Interferencia de ARN , ARN Interferente Pequeño/genética , Transducción de Señal/inmunología , Linfocitos T/inmunología , Proteína 1 de Unión a la X-Box/biosíntesis
8.
Proc Natl Acad Sci U S A ; 114(31): E6400-E6409, 2017 08 01.
Artículo en Inglés | MEDLINE | ID: mdl-28698369

RESUMEN

T-follicular helper (Tfh) cells differentiate through a multistep process, culminating in germinal center (GC) localized GC-Tfh cells that provide support to GC-B cells. T-follicular regulatory (Tfr) cells have critical roles in the control of Tfh cells and GC formation. Although Tfh-cell differentiation is inhibited by IL-2, regulatory T (Treg) cell differentiation and survival depend on it. Here, we describe a CD25- subpopulation within both murine and human PD1+CXCR5+Foxp3+ Tfr cells. It is preferentially located in the GC and can be clearly differentiated from CD25+ non-GC-Tfr, Tfh, and effector Treg (eTreg) cells by the expression of a wide range of molecules. In comparison to CD25+ Tfr and eTreg cells, CD25- Tfr cells partially down-regulate IL-2-dependent canonical Treg features, but retain suppressive function, while simultaneously up-regulating genes associated with Tfh and GC-Tfh cells. We suggest that, similar to Tfh cells, Tfr cells follow a differentiation pathway generating a mature GC-localized subpopulation, CD25- Tfr cells.


Asunto(s)
Centro Germinal/citología , Centro Germinal/inmunología , Subunidad alfa del Receptor de Interleucina-2/genética , Linfocitos T Colaboradores-Inductores/inmunología , Linfocitos T Reguladores/inmunología , Animales , Regulación hacia Abajo/inmunología , Factores de Transcripción Forkhead/biosíntesis , Humanos , Subunidad alfa del Receptor de Interleucina-2/biosíntesis , Tejido Linfoide/citología , Tejido Linfoide/inmunología , Ratones , Ratones Endogámicos BALB C , Ratones Endogámicos C57BL , Ratones Noqueados , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Proteínas Proto-Oncogénicas/biosíntesis , Receptores CXCR5/biosíntesis , Proteínas Represoras/biosíntesis
9.
Sci Rep ; 6: 30004, 2016 08 02.
Artículo en Inglés | MEDLINE | ID: mdl-27481356

RESUMEN

Although originally identified as a B cell differentiation factor, it is now known that mammalian interleukin-6 (IL-6) only regulates B cells committed to plasma cells in response to T-dependent (TD) antigens within germinal centers (GCs). Even though adaptive immunity is present in teleost fish, these species lack lymph nodes and GCs. Thus, the aim of the present study was to establish the role of trout IL-6 on B cells, comparing its effects to those induced by bacterial lipopolysaccharide (LPS). We demonstrate that the effects of teleost IL-6 on naïve spleen B cells include proliferation, activation of NF-κB, increased IgM secretion, up-regulation of Blimp1 transcription and decreased MHC-II surface expression that point to trout IL-6 as a differentiation factor for IgM antibody-secreting cells (ASCs). However, LPS induced the secretion of IgM without up-regulating Blimp1, driving the cells towards an intermediate activation state in which antigen presenting mechanisms are elicited together with antibody secretion and expression of pro-inflammatory genes. Our results reveal that, in trout, IL-6 is a differentiation factor for B cells, stimulating IgM responses in the absence of follicular structures, and suggest that it was after follicular structures appeared that this cytokine evolved to modulate TD responses within the GC.


Asunto(s)
Linfocitos B/inmunología , Centro Germinal/inmunología , Inmunoglobulina M/biosíntesis , Interleucina-6/farmacología , Lipopolisacáridos/farmacología , Oncorhynchus mykiss/inmunología , Animales , Linfocitos B/citología , Proliferación Celular/efectos de los fármacos , Activación Enzimática/efectos de los fármacos , Inmunoglobulina M/inmunología , Interleucina-6/inmunología , Lipopolisacáridos/inmunología , FN-kappa B/inmunología , Factor 1 de Unión al Dominio 1 de Regulación Positiva/biosíntesis , Transcripción Genética/efectos de los fármacos , Activación Transcripcional/efectos de los fármacos , Regulación hacia Arriba/efectos de los fármacos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA